Screener
Agios Pharmaceuticals AGIO Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 51,547 | 45,869 | 99,851 | 87,396 |
| Total operating expenses | 155,297 | 139,511 | 286,068 | 254,866 |
| Loss from operations | (110,552) | (127,056) | (220,577) | (233,685) |
| Interest income, net | 9,730 | 14,513 | 20,525 | 30,600 |
| Other income, net | 119 | 523 | 238 | 1,776 |
| Net loss | $(100,703) | $(112,020) | $(199,814) | $(201,309) |
| Net loss per share - basic and diluted | $(1.69) | $(1.93) | $(3.38) | $(3.49) |
| Weighted-average number of common shares used in computing net loss per share – basic and diluted | 59,488,871 | 57,932,576 | 59,137,508 | 57,697,193 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's net income?
- Agios Pharmaceuticals (AGIO) reported net income of -$100.7M in Q2 2026.
- How has Agios Pharmaceuticals's net income changed year-over-year?
- Agios Pharmaceuticals's net income increased by 10.1% year-over-year, from -$112.02M to -$100.7M.
- What is the long-term trend for Agios Pharmaceuticals's net income?
- Over 2 years (2021 to 2025), Agios Pharmaceuticals's net income has grown at a -50.7% compound annual growth rate (CAGR), from $1.7B to -$412.78M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Agios Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude